A PLACEBO-CONTROLLED DOUBLE-BLIND-STUDY OF EPALRESTAT (ONO-2235) IN PATIENTS WITH DIABETIC NEUROPATHY

被引：20
|
作者：
GOTO, Y [1 ]
HOTTA, N [1 ]
SHIGETA, Y [1 ]
SAKAMOTO, N [1 ]
KITO, S [1 ]
MATSUOKA, K [1 ]
TAKAHASHI, A [1 ]
KIKKAWA, R [1 ]
SAKUMA, A [1 ]
机构：
[1] NAGOYA UNIV,SCH MED,DEPT INTERNAL MED 3,65 TSURUMAI CHO,SHOWA KU,NAGOYA,AICHI 466,JAPAN
来源：
DIABETIC MEDICINE | 1993年 / 10卷 / 05期
关键词：
ALDOSE REDUCTASE INHIBITOR; CLINICAL TRIALS; DIABETIC NEUROPATHY; EPALRESTAT; HEMOGLOBIN A1C; NERVE CONDUCTION VELOCITY;
D O I：
10.1111/j.1464-5491.1993.tb00197.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：S39 / S43
页数：5
相关论文
共 50 条
  • [31] Efficacy and safety of pregabalin for painful diabetic peripheral neuropathy in a population of Chinese patients: A randomized placebo-controlled trial
    Mu, Yiming
    Liu, Xiaomin
    Li, Quanmin
    Chen, Kangning
    Liu, Yu
    Lv, Xiaofeng
    Xu, Xiangjin
    Fan, Dongsheng
    Shang, Ningxiu
    Yang, Ruoyong
    Pauer, Lynne
    Pan, Changyu
    JOURNAL OF DIABETES, 2018, 10 (03) : 256 - 265
  • [32] A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients
    Murakami, Masato
    Osada, Kenichi
    Mizuno, Hiromichi
    Ochiai, Toshimitsu
    Alev, Levent
    Nishioka, Kusuki
    ARTHRITIS RESEARCH & THERAPY, 2015, 17
  • [33] A Randomized, Double-Blind, Placebo-Controlled Trial of Olanzapine in the Treatment of Trichotillomania
    Van Ameringen, Michael
    Mancini, Catherine
    Patterson, Beth
    Bennett, Mark
    Oakman, Jonathan
    JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (10) : 1336 - 1343
  • [34] A Randomized Withdrawal, Placebo-Controlled Study Evaluating the Efficacy and Tolerability of Tapentadol Extended Release in Patients With Chronic Painful Diabetic Peripheral Neuropathy
    Vinik, Aaron I.
    Shapiro, Douglas Y.
    Rauschkolb, Christine
    Lange, Bernd
    Karcher, Keith
    Pennett, Deborah
    Etropolski, Mila S.
    DIABETES CARE, 2014, 37 (08) : 2302 - 2309
  • [35] RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFECT OF THE ACTH4-9 ANALOG ORG 2766 IN IDDM PATIENTS WITH NEUROPATHY
    BRAVENBOER, B
    HENDRIKSE, PH
    OEY, PL
    VANHUFFELEN, AC
    GROENHOUT, C
    GISPEN, WH
    ERKELENS, DW
    DIABETOLOGIA, 1994, 37 (04) : 408 - 413
  • [36] NAFTIDROFURYL FOR THE PREVENTION OF PERIPHERAL NEUROPATHY INDUCED BY VINCRISTINE - A RANDOMIZED PLACEBO-CONTROLLED STUDY IN 29 PATIENTS
    LEGER, JM
    GABARRE, J
    EMILE, J
    LONCHAMPT, P
    BOUCHE, P
    MOSNIER, M
    SEMAINE DES HOPITAUX, 1994, 70 (15-16): : 467 - 471
  • [37] Results of Mirogabalin Treatment for Diabetic Peripheral Neuropathic Pain in Asian Subjects: A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Study
    Baba, Masayuki
    Kuroha, Masanori
    Ohwada, Shoichi
    Murayama, Emiko
    Matsui, Norimitsu
    PAIN AND THERAPY, 2020, 9 (01) : 261 - 278
  • [38] Impact of evolocumab on the pharmacodynamic profiles of clopidogrel in patients with atherosclerotic cardiovascular disease: a randomised, double-blind, placebo-controlled study
    Franchi, Francesco
    Ortega-Paz, Luis
    Rollini, Fabiana
    Been, Latonya
    Rivas, Andrea
    Maaliki, Naji
    Zhou, Xuan
    Pineda, Andres M.
    Suryadevara, Siva
    Soffer, Daniel
    Zenni, Martin
    Angiolillo, Dominick J.
    Neumann, Franz-Josef
    EUROINTERVENTION, 2023, 18 (15) : 1254 - +
  • [39] Adjunctive Cariprazine for the Treatment of Patients With Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study
    Sachs, Gary S.
    Yeung, Paul P.
    Rekeda, Ludmyla
    Khan, Arifulla
    Adams, Julie L.
    Fava, Maurizio
    AMERICAN JOURNAL OF PSYCHIATRY, 2023, 180 (03) : 241 - 251
  • [40] Metformin for knee osteoarthritis with obesity: study protocol for a randomised, double-blind, placebo-controlled trial
    Lim, Yuan Z.
    Wang, Yuanyuan
    Urquhart, Donna M.
    Estee, Mahnuma Mahfuz
    Wluka, Anita E.
    Heritier, Stephane
    Cicuttini, Flavia M.
    BMJ OPEN, 2023, 13 (12):
12345